← Back to all trials
Active Not Recruiting
NCT06279221
Litfulo Capsules Special Investigation
Conditions: Alopecia Areata
Sex: All
Ages: 0 Years – N/A
Healthy volunteers: No
Enrollment: 664
Sponsor: Pfizer
Location: Pfizer Tokyo
Summary
The objective of this Study is to confirm the safety during the long-term use of this drug and the effectiveness during the use of this drug under the actual use in the patients treated with this drug.
Eligibility Criteria
Inclusion Criteria:
Patients must meet all of the following inclusion criteria to be eligible for inclusion in the study:
* Patients with alopecia areata who start receiving this drug for the first time after the contract date of this study
* Patients who have not participated in a clinical trial (clinical study) of this drug
Exclusion Criteria:
Patients meeting any of the following criteria will not be included in the study:
* Patients previously enrolled in this study
* Patients with a history of treatment with this drug (including investigational product)
Source: ClinicalTrials.gov (NCT06279221). StuddyBuddy aggregates publicly available trial information.